C4U Corporation

[On Demand]
C4U was founded based on CRISPR-Cas3 genome editing technology in 2018. CRISPR-Cas3 has several features that are differentiated from Cas9 and better than Cas9. C4U will use Cas3 technology in the fields of pharmaceutical, agriculture and industry.
Therefore, through Bio Digital, C4U would like to make a contact with pharmaceutical companies that have an interest in gene therapy and cell treatment. Also, a company that has an interest in utilizing Cas3 for its services or business is welcome and highly appreciated.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
President and CEO
C4U Corporation